T cell receptor induced intracellular redistribution of type I protein kinase A

Wenhong Zhou1, Leoncio Vergara, Rolf König

  • 1Department of Microbiology and Immunology, The University of Texas Medical Branch, 301 University Boulevard, Galveston, TX 77555, USA.

Immunology
|November 24, 2004
PubMed

Insights

Cyclic AMP-dependent protein kinase A (PKA) type I regulates T-cell activation by relocating within the cell after T-cell receptor stimulation. This spatial redistribution of PKA type I is crucial for controlling T-cell responses.

Area of Science:

  • Immunology
  • Cell Biology
  • Molecular Biology

Background:

  • T-cell activation, proliferation, and cytokine secretion depend on regulated cyclic AMP levels.
  • Cyclic AMP-dependent protein kinase A (PKA) is a key effector of cyclic AMP signaling in mammalian cells.
  • Type I PKA isozyme plays an inhibitory role in T-cell activation.

Purpose of the Study:

  • To investigate the role of spatial redistribution of PKA type I in regulating T-cell activation.
  • To understand the temporal and spatial dynamics of PKA type I following T-cell receptor (TCR) stimulation.

Main Methods:

  • Laser scanning confocal microscopy was used to visualize PKA type I localization in T cells.
  • T-cell activation was induced via antigen engagement or antibody-mediated cross-linking of the TCR-associated CD3 complex.
  • PKA type I and TCR distribution were monitored over time after stimulation.

Main Results:

  • In resting T cells, PKA type I was uniformly distributed.
  • Upon TCR stimulation, PKA type I rapidly redistributed to the opposite pole from the TCR concentration at the immunological synapse within 10 minutes.
  • This segregation was maintained for at least 20 minutes, with partial overlap at 30 minutes, and returned to baseline distribution by 60 minutes.

Conclusions:

  • TCR signaling induces a dynamic spatial redistribution of PKA type I, crucial for regulating T-cell activation.
  • The observed PKA type I redistribution suggests a mechanism for targeting or excluding the enzyme from specific subcellular locations based on cyclic AMP levels.
  • This dynamic localization of PKA type I is a key regulatory event in T-cell immune responses.

Related Concept Videos

Intracellular Signaling Cascades01:24

Intracellular Signaling Cascades

Once a ligand binds to a receptor, the signal is transmitted through the membrane and into the cytoplasm. The continuation of a signal in this manner is called signal transduction. Signal transduction only occurs with cell-surface receptors, which cannot interact with most components of the cell, such as DNA. Only internal receptors can interact directly with DNA in the nucleus to initiate protein synthesis. When a ligand binds to its receptor, conformational changes occur that affect the...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...